Fig. 2.

Scatterplots of the observed concentrations of meropenem and biapenem in plasma (40 samples) and bile (80 samples) versus the individual predicted concentrations based on the population pharmacokinetic model parameters for each drug (Table 3). The lines represent unity (y = x).